Non remboursé par l'Assurance maladie achat Viagra pour acheter du Viagra à partir de la boutique en ligne sécurisé. De 20 a 30 % en fonction des pharmacies.

Här hittar du alla produkter från levitra på nätet. Fri frakt, smidiga leveranser och trygga köp. Besök ditt närmaste apotek eller handla online idag.

Levitra er ansvarlig for utvidelse og avslapning i blodårene som frakter blod til penis kjøp levitra generisk på apoteket I Norge.

Søger du et apotek hvor du kan købe Levitra online i Danmark? Køb levitra online i Danmark tryk venligst her! Køb Levitra uden recept.

Яка школи англійської мови онлайн в Україні користується найбільшою популярністю? Дізнатися це можна на сторінках нашого сайту в рейтингу.

МФО охоче видають кредит під 0 відсотків на картку в Україні, якщо знають, що потенційний клієнт точно поверне заборгованість.

Без застави, перевірок та поручителів кредит на будь-які цілі під вигідний відсоток. Головне вчасно повернути борг із кредиту.

Збір величезної кількості документів в минулому. Сьогодні онлайн кредит без довідки про доходи на картку видають всім підряд.

Коли людина потрапляє в складну фінансову ситуацію, йому потрібен кредит без дзвінків терміново на картку. Це реальне рішення.

Top Panel
Authentification
Top Panel
Helpdesk biocides
Helpdesk biocides
Rejected substances PDF Print E-mail
Written by DPR Biocides - Anses   

This section provides a non-exhaustive list of the non-approval decisions that are applicable to all European countries. They are specific to an active substance/ product type combination.

Commission implementing Decision (EU) 2022/2570 of 24 November 2022 pdfnot approving silver nitrate as an active substance for use in biocidal products of product-types 7 in accordance with Regulation ( EU) No 528/2012 of the European Parliament and of the Council

Commission implementing Decision (EU) 2022/2327 of 24 November 2022 pdfnot approving chloramin B as an active substance for use in biocidal products of product-types 2, 3, 4 and 5 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission implementing Decision (EU) 2022/2326 of 24 November 2022 pdf not approving epsilon-metofluthrin as an active substance for use in biocidal products of producttype 19 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission implementing Decision (EU) 2022/2325 of 24 November 2022 pdf not approving 1,2-benzisothiazol-3(2H)-one (BIT) as an active substance for use in biocidal products of product-type 10 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission implementing Decision (EU) 2022/2005 of 21 October 2022 pdf not approving methylene dithiocyanate as an existing active substance for use in biocidal products of product-type 12 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission implementing Decision (EU) 2022/1990 of 20 October 2022 pdf cancelling the approval of tolylfluanid as an active substance for use in biocidal products of producttype 7 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission implementing Decision (EU) 2022/986 of 23 June 2022 pdf not approving N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine as an existing active substance for use in biocidal products of product-type 8

Commission implementing Decision (EU) 2021/1283 of 2 August 2021 pdf on the non-approval of certain biocidal active substances pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission implementing Decision (EU) 2021/103 of 29 January 2021 pdf not approving carbon dioxide as an existing active substance for use in biocidal products for product-type 19

Commission implementing Decision (EU) 2021/98 of 28 January 2021 pdf not approving esbiothrin as an existing active substance for use in biocidal products for product-type 18

Commission implementing Decision (EU) 2020/1765 of 25 November 2020 pdf not approving chlorophene as an existing active substance for use in biocidal products for product-type 2

Commission implementing Decision (EU) 2020/1036 of 15 July 2020 pdf on the non-approval of certain biocidal active substances pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission implementing Decision (EU) 2019/1973 of 27 november 2019 pdf not approving silver copper zeolite as an existing active substance for use in biocidal products for product-type 2 and 7

Commission implementing Decision (EU) 2019/1960 of 26 november 2019 pdf not approving silver zeolite as an existing active substance for use in biocidal products for product-type 2 and 7

Commission implementing Decision (EU) 2019/1959 of 26 november 2019 pdf not approving silver sodium hydrogen zirconium phosphate as an existing active substance for use in biocidal products for product-type 2 and 7

Commission implementing Decision (EU) 2019/1942 of 22 november 2019 pdf not approving carbendazim as an existing active substance for use in biocidal products for product-type 9

Corrigendum to commission implementing Decision (EU) 2018/1622 of 29 October 2018 pdf on the non-approval of certain biocidal active substances pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission implementing Decision (EU) 2018/1985 of 13 december 2018 pdf not approving "Willaertia magma C2c Maky" as an active substance for use in biocidal products for product-type 11

Commission implementing Decision (EU) 2018/1622 of 29 October 2018 pdf on the non-approval of certain biocidal active substances pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission implementing Decision (EU) 2018/1251 of 18 September 2018 pdf not approving empenthrin as an existing active substance for use in biocidal products for product-type 18

Commission implementing Decision (EU) 2018/622 of 20 April 2018 pdf not approving chlorophene as an existing active substance for use in biocidal products for product-type 3

Commission implementing Decision (EU) 2018/619 of 20 April 2018 pdf not approving PHMB (1415; 4.7) as an existing active substance for use in biocidal products for product-type 1,  5 and 6

Commission implementing Decision (EU) 2017/1282 of 14 July 2017 pdf not approving 2-méthyl-1,2-benzisothiazol-3(2H)-one as an existing active substance for use in biocidal products for product-type 13

Commission implementing Decision (EU) 2017/802 of 10 May 2017 pdf not approving PHMB (1600; 1.8) as an existing active substance for use in biocidal products for product-type 5

Commission implementing Decision (EU) 2016/1950 of 4 November 2016 pdf on the non-approval of certain biocidal active substances pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission implementing Decision (EU) 2016/110 of 27 January 2016 pdf not approving triclosan as an active substance for use in biocidal products for product-type 1

Commission implementing Decision (EU) 2016/109 of 27 January 2016 pdf not to approve PHMB (1600; 1.8) as an active substance for use in biocidal products for product-types 1, 6 and 9

Commission implementing Decision (EU) 2016/108 of 27 January 2016 pdf not approving 2-Butanone, peroxide as an active substance for use in biocidal products for product-types 1 and 2

Commission implementing Decision (EU) 2016/107 of 27 January 2016 pdf not approving cybutryne as an active substance for use in biocidal products for product-type 21

Commission implementing Decision (EU) 2015/1736 of 28 September 2015 pdf not approving triflumuron as an active substance for use in biocidal products for product-type 18

Commission implementing Decision 2014/227/EU of 24 April 2014 pdf on the non-approval of certain biocidal active substances pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission Decision 2013/204/EU of 27 April 2013 pdf concerning the non-inclusion of formaldehyde for product-type 20 in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2013/85/EU of 14 February 2013 pdf concerning the non-inclusion of certain substances in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2012/728/EU of 23 November 2012 pdf concerning the non-inclusion of bifenthrin for product type 18 in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2012/257/EU of 11 May 2012 pdf concerning the non-inclusion of naled for product type 18 in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2012/254/EU of 10 May 2012 pdf concerning the non-inclusion of dichlorvos for product type 18 in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2012/78/EU of 1 February 2012 pdf concerning the non-inclusion of certain substances in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2012/77/EU of 1 February 2012 pdf concerning the non-inclusion of flufenoxuron for product type 18 in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2011/391/EU of 1 July 2011 pdf concerning the non-inclusion of certain substances in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2010/675/EU of 8 November 2010 pdf concerning the non-inclusion of certain substances in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2010/72/EU of 8 February 2010 pdf concerning the non-inclusion of certain substances in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2010/71/EU of 8 February 2010 pdf concerning the non-inclusion of diazinon in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2009/324/EC of 14 April 2009 pdf concerning the non-inclusion of certain substances in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2009/322/EC of 8 April 2009 pdf concerning the non-inclusion of certain substances in Annexes I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2008/809/EC of 14 October 2008 pdf concerning the non-inclusion of certain substances in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2008/681/EC of 28 July 2008 pdf concerning the non-inclusion of certain substances in Annexes I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2007/597/EC of 27 August 2007 pdf concerning the non-inclusion of guazatine triacetate in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market

Commission Decision 2007/565/EC of 14 August 2007 pdf concerning the non-inclusion in Annex I, IA or IB to Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market of certain substances to be examined under the 10-year work programme referred to in Article 16(2) thereof

Last Updated on Wednesday, 04 January 2023 09:38